| Literature DB >> 26108893 |
Megan M Weivoda1, Ming Ruan1, Larry Pederson1, Christine Hachfeld1, Rachel A Davey2, Jeffrey D Zajac2, Jennifer J Westendorf3, Sundeep Khosla1, Merry Jo Oursler1.
Abstract
Osteoblast-mediated bone formation is coupled to osteoclast-mediated bone resorption. These processes become uncoupled with age, leading to increased risk for debilitating <span class="Disease">fractures. Therefore, understanding how osteoblasts are recruited to sites of resorption is vital to treating age-related <span class="Disease">bone loss. Osteoclasts release and activate TGF-β from the bone matrix. Here we show that osteoclast-specific inhibition of TGF-β receptor signaling in mice results in osteopenia due to reduced osteoblast numbers with no significant impact on osteoclast numbers or activity. TGF-β induced osteoclast expression of Wnt1, a protein crucial to normal bone formation, and this response was blocked by impaired TGF-β receptor signaling. Osteoclasts in aged murine bones had lower TGF-β signaling and Wnt1 expression in vivo. Ex vivo stimulation of osteoclasts derived from young or old mouse bone marrow macrophages showed no difference in TGF-β-induced Wnt1 expression. However, young osteoclasts expressed reduced Wnt1 when cultured on aged mouse bone chips compared to young mouse bone chips, consistent with decreased skeletal TGF-β availability with age. Therefore, osteoclast responses to TGF-β are essential for coupling bone resorption to bone formation, and modulating this pathway may provide opportunities to treat age-related bone loss.Entities:
Keywords: BONE REMODELING; COUPLING; OSTEOCLAST; TGF-β; WNT1
Mesh:
Substances:
Year: 2015 PMID: 26108893 PMCID: PMC4758668 DOI: 10.1002/jbmr.2586
Source DB: PubMed Journal: J Bone Miner Res ISSN: 0884-0431 Impact factor: 6.741